Logo
x

Search

Subscribe Now

arrowhead pharmaceuticals

Arrowhead Pharmaceuticals Commences P-I/IIa Trial of ARO-INHBE to Treat Obesity

Arrowhead Pharmaceuticals Commences P-I/IIa Trial of ARO-INHBE to Treat Obesity

  • December 24, 2024
Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS...

  • September 3, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.